CMR Surgical

CMR Surgical is on a mission to transform surgery globally by making robotic-assisted minimal access surgery more accessible to hospitals and patients. Founded in 2014 and headquartered in Cambridge, UK, the company has developed the Versius and next-generation Versius Plus systems, which are modular, portable, and designed to fit flexibly into existing operating rooms without requiring dedicated space. With recent FDA clearance for the U.S. market and over $200 million in new funding secured in 2025, CMR is positioned as a key challenger in the soft-tissue surgical robotics space, aiming to disrupt the status quo through its adaptable technology and partnership-focused approach.

The Versius Surgical Robotic System is a modular, portable, and adaptable platform for robotic-assisted minimal access surgery, featuring a digital ecosystem with data analytics tools and an integrated fluorescence visualization system (vLimeLite).

Total raised: $455M

CMR Surgical's main competitor is Intuitive Surgical, the long-established leader with the da Vinci system. CMR differentiates through its modular, portable design that doesn't require a dedicated operating room, its partnership-focused commercial model, and its integrated digital ecosystem for surgical data and operational analytics.